These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 15486771)
1. Acute asthma attack caused by ophthalmic application of antiallergic agents. Uchio E; Kadonosono K Jpn J Ophthalmol; 2004; 48(5):475-7. PubMed ID: 15486771 [TBL] [Abstract][Full Text] [Related]
2. Comparison of efficacy of bromfenac sodium 0.1% ophthalmic solution and fluorometholone 0.02% ophthalmic suspension for the treatment of allergic conjunctivitis. Fujishima H; Fukagawa K; Takano Y; Tanaka M; Okamoto S; Miyazaki D; Yamada J; Fukushima A; Uchio E; Nakagawa Y J Ocul Pharmacol Ther; 2009 Jun; 25(3):265-70. PubMed ID: 19348602 [TBL] [Abstract][Full Text] [Related]
3. Treatment of allergic conjunctivitis: results of a 1-month, single-masked randomized study. Figus M; Fogagnolo P; Lazzeri S; Capizzi F; Romagnoli M; Canovetti A; Iester M; Ferreras A; Rossetti L; Nardi M Eur J Ophthalmol; 2010; 20(5):811-8. PubMed ID: 20383847 [TBL] [Abstract][Full Text] [Related]
4. Efficacy of olopatadine HCI 0.1%, ketotifen fumarate 0.025%, epinastine HCI 0.05%, emedastine 0.05% and fluorometholone acetate 0.1% ophthalmic solutions for seasonal allergic conjunctivitis: a placebo-controlled environmental trial. Borazan M; Karalezli A; Akova YA; Akman A; Kiyici H; Erbek SS Acta Ophthalmol; 2009 Aug; 87(5):549-54. PubMed ID: 18631332 [TBL] [Abstract][Full Text] [Related]
5. Comparison of the effects of ketotifen fumarate 0.025% and olopatadine HCl 0.1% ophthalmic solutions in seasonal allergic conjunctivities: a 30-day, randomized, double-masked, artificial tear substitute-controlled trial. Avunduk AM; Tekelioglu Y; Turk A; Akyol N Clin Ther; 2005 Sep; 27(9):1392-402. PubMed ID: 16291412 [TBL] [Abstract][Full Text] [Related]
6. Cyclosporine A eye drops inhibit the early-phase reaction in a type-I allergic conjunctivitis model in mice. Shii D; Oda T; Shinomiya K; Katsuta O; Nakamura M J Ocul Pharmacol Ther; 2009 Aug; 25(4):321-8. PubMed ID: 19650707 [TBL] [Abstract][Full Text] [Related]
7. A comparison of the clinical efficacy of pheniramine maleate/naphazoline hydrochloride ophthalmic solution and olopatadine hydrochloride ophthalmic solution in the conjunctival allergen challenge model. Greiner JV; Udell IJ Clin Ther; 2005 May; 27(5):568-77. PubMed ID: 15978305 [TBL] [Abstract][Full Text] [Related]
8. [A case of bronchial asthma and PIE Syndrome induced by disodium cromoglycate]. Soda R; Miyagawa H; Isozima K; Sunami K; Nanba K; Araki M; Okada K; Tuji K; Nakatou K; Tada S Nihon Kyobu Shikkan Gakkai Zasshi; 1989 Jan; 27(1):87-91. PubMed ID: 2501549 [TBL] [Abstract][Full Text] [Related]
9. [Therapy of chronic allergic conjunctivitis with sodium cromoglycate (lecrolin)]. Polunin GS; Makarov IA Vestn Oftalmol; 1997; 113(2):21-2. PubMed ID: 9229898 [TBL] [Abstract][Full Text] [Related]
10. Management of severe allergic conjunctivitis with topical cyclosporin a 0.05% eyedrops. Ozcan AA; Ersoz TR; Dulger E Cornea; 2007 Oct; 26(9):1035-8. PubMed ID: 17893529 [TBL] [Abstract][Full Text] [Related]
11. Effects of topical application of ibudilast for seasonal allergic conjunctivitis in patients wearing soft contact lenses. Sakuma K; Toshida H; Honda R; Tanaka K; Fukazawa A; Takahashi K; Suto C; Ebihara N; Murakami A Eye Contact Lens; 2009 Sep; 35(5):251-4. PubMed ID: 19672196 [TBL] [Abstract][Full Text] [Related]
12. Effects of topical anti-inflammatory and antiallergic eyedrops on prostaglandin E2-induced aqueous flare elevation in pigmented rabbits. Hayasaka Y; Hayasaka S; Zhang XY; Nagaki Y Arch Ophthalmol; 2002 Jul; 120(7):950-3. PubMed ID: 12096966 [TBL] [Abstract][Full Text] [Related]